Last updated: 26 June 2024 at 4:30pm EST

Tolga Tanguler Net Worth




The estimated Net Worth of Tolga Tanguler is at least $4.89 million dollars as of 24 June 2024. Tolga Tanguler owns over 1,605 units of Alnylam Pharmaceuticals Inc stock worth over $3,053,871 and over the last 3 years Tolga sold ALNY stock worth over $1,840,439.

Tolga Tanguler ALNY stock SEC Form 4 insiders trading

Tolga has made over 8 trades of the Alnylam Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Tolga sold 1,605 units of ALNY stock worth $370,755 on 24 June 2024.

The largest trade Tolga's ever made was exercising 5,026 units of Alnylam Pharmaceuticals Inc stock on 1 February 2022 worth over $1,316,360. On average, Tolga trades about 1,923 units every 79 days since 2022. As of 24 June 2024 Tolga still owns at least 11,660 units of Alnylam Pharmaceuticals Inc stock.

You can see the complete history of Tolga Tanguler stock trades at the bottom of the page.



What's Tolga Tanguler's mailing address?

Tolga's mailing address filed with the SEC is 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142.

Insiders trading at Alnylam Pharmaceuticals Inc

Over the last 20 years, insiders at Alnylam Pharmaceuticals Inc have traded over $140,068,015 worth of Alnylam Pharmaceuticals Inc stock and bought 4,419,116 units worth $1,983,132,563 . The most active insiders traders include Sanofi, Christoph H Westphal et Kevin P Starr. On average, Alnylam Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of $11,181,724. The most recent stock trade was executed by Yvonne Greenstreet on 20 August 2024, trading 15,000 units of ALNY stock currently worth $1,275,000.



What does Alnylam Pharmaceuticals Inc do?

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.



What does Alnylam Pharmaceuticals Inc's logo look like?

Alnylam Pharmaceuticals Inc logo

Complete history of Tolga Tanguler stock trades at Alnylam Pharmaceuticals Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
24 Jun 2024 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Vente 1,605 $231.00 $370,755
24 Jun 2024
11,660
27 Feb 2024 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Exercice d'option 1,667 $159.00 $265,053
27 Feb 2024
5,737
15 Feb 2024 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Vente 1,009 $148.06 $149,393
15 Feb 2024
4,070
26 Apr 2023 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Vente 1,476 $194.59 $287,215
26 Apr 2023
1,801
1 Feb 2023 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Exercice d'option 5,025 $224.91 $1,130,173
1 Feb 2023
5,025
3 Aug 2022 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Vente 3,595 $214.18 $769,977
3 Aug 2022
0
5 Jul 2022 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Vente 1,754 $150.00 $263,100
5 Jul 2022
1,754
1 Feb 2022 Tolga Tanguler
Vice-président exécutif et Chief Commercial Officer
Exercice d'option 5,026 $144.93 $728,418
1 Feb 2022
5,026


Alnylam Pharmaceuticals Inc executives and stock owners

Alnylam Pharmaceuticals Inc executives and other stock owners filed with the SEC include: